279 related articles for article (PubMed ID: 28392404)
1. A global perspective on FOXO1 in lipid metabolism and lipid-related diseases.
Li Y; Ma Z; Jiang S; Hu W; Li T; Di S; Wang D; Yang Y
Prog Lipid Res; 2017 Apr; 66():42-49. PubMed ID: 28392404
[TBL] [Abstract][Full Text] [Related]
2. Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.
Sabir U; Irfan HM; Alamgeer ; Umer I; Niazi ZR; Asjad HMM
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):741-755. PubMed ID: 35357518
[TBL] [Abstract][Full Text] [Related]
3. A Review of
Peng S; Li W; Hou N; Huang N
Cells; 2020 Jan; 9(1):. PubMed ID: 31936903
[No Abstract] [Full Text] [Related]
4. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
[TBL] [Abstract][Full Text] [Related]
5. Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?
Zhang X; Jiang L; Liu H
Drug Des Devel Ther; 2021; 15():1851-1860. PubMed ID: 33976536
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of FOXO1 in adipocyte differentiation.
Chen J; Lu Y; Tian M; Huang Q
J Mol Endocrinol; 2019 Apr; 62(3):R239-R253. PubMed ID: 30780132
[TBL] [Abstract][Full Text] [Related]
8. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.
Yang Z; Roth K; Agarwal M; Liu W; Petriello MC
J Nutr Biochem; 2021 Sep; 95():108633. PubMed ID: 33789150
[TBL] [Abstract][Full Text] [Related]
9. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4.
Song J; Ren P; Zhang L; Wang XL; Chen L; Shen YH
Biochem Biophys Res Commun; 2010 Feb; 393(1):89-94. PubMed ID: 20102700
[TBL] [Abstract][Full Text] [Related]
10. Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?
Menghini R; Casagrande V; Iuliani G; Rizza S; Mavilio M; Cardellini M; Federici M
Int J Biochem Cell Biol; 2020 Jan; 118():105659. PubMed ID: 31765819
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells.
Kuo YT; Lin TH; Chen WL; Lee HM
Eur J Pharmacol; 2012 Oct; 692(1-3):10-8. PubMed ID: 22819708
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box O1 in grass carp Ctenopharyngodon idella: Molecular characterization, gene structure, tissue distribution and mRNA expression in insulin-inhibited adipocyte lipolysis.
Sun J; Xiao PZ; Chang ZG; Ji H; Du ZY; Chen LQ
Comp Biochem Physiol A Mol Integr Physiol; 2017 Feb; 204():76-84. PubMed ID: 27872010
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
14. Novel Transcriptional Mechanisms for Regulating Metabolism by Thyroid Hormone.
Singh BK; Sinha RA; Yen PM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360449
[TBL] [Abstract][Full Text] [Related]
15. [Glucagon-like peptide-1 regulates lipid metabolism in hepatocytes through Foxo1/3].
Li L; Zha M; Zhang LY; Wang XF; Zhu ZH; Zou DJ
Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):39-42. PubMed ID: 30605949
[No Abstract] [Full Text] [Related]
16. Mammalian target of rapamycin complex 1 and FoxO1 in the transcriptional control of lipolysis and de novo lipogenesis.
Kandror KV
Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):326-331. PubMed ID: 28841634
[TBL] [Abstract][Full Text] [Related]
17. Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins.
Zhang W; Bu SY; Mashek MT; O-Sullivan I; Sibai Z; Khan SA; Ilkayeva O; Newgard CB; Mashek DG; Unterman TG
Cell Rep; 2016 Apr; 15(2):349-59. PubMed ID: 27050511
[TBL] [Abstract][Full Text] [Related]
18. Chinese herb extract improves liver steatosis by promoting the expression of high molecular weight adiponectin in NAFLD rats.
Liu X; Tong W; Zhao X; Zhang H; Tang Y; Deng X
Mol Med Rep; 2017 Oct; 16(4):5580-5586. PubMed ID: 28849192
[TBL] [Abstract][Full Text] [Related]
19. β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.
Kamikubo R; Kai K; Tsuji-Naito K; Akagawa M
Mol Nutr Food Res; 2016 Oct; 60(10):2228-2242. PubMed ID: 27234712
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the roles of FOXO1 in human neoplasms.
Jiang S; Li T; Yang Z; Hu W; Yang Y
Int J Cancer; 2018 Oct; 143(7):1560-1568. PubMed ID: 29473160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
